DTL
AVNR

Dynamic Technology Lab’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Dynamic Technology Lab’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,696
Closed -$66K – 1039
2014
Q2 		$66K Buy
+11,696
New +$53.9K 0.03% 622
2013
Q4 		– Sell
-20,649
Closed -$88K – 806
2013
Q3 		$88K Buy
20,649
+1,971
+11% +$9.34K 0.07% 426
2013
Q2 		$86K Buy
+18,678
New +$64.2K 0.09% 347

Other funds holding AVNR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

Dynamic Technology Lab's AVNR Position: Q3 2014 in Review

Dynamic Technology Lab sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q3 2014, closing a stake of 11,696 shares — an estimated $66K sold.

Dynamic Technology Lab first reported a position in AVNR in Q2 2013 and held it in 3 quarters. The position peaked at $88K in Q3 2013. 142 funds tracked by Wall St. Rank hold AVNR as of Q3 2014.

  • Dynamic Technology Lab reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q3 2014 after selling out during the quarter.
  • Dynamic Technology Lab sold 11,696 AVANIR PHARMACEUTICALS, INC CL A shares in Q3 2014, an estimated $66K.
  • Dynamic Technology Lab first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 3 quarters.
  • Dynamic Technology Lab's AVANIR PHARMACEUTICALS, INC CL A position peaked at $88K in Q3 2013.
  • 142 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q3 2014.

Based on Dynamic Technology Lab's 13F filing for Q3 2014, filed 12 Nov 2014.